Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 19269682 | LACTATION ASSEMBLY | July 2025 | August 2025 | Allow | 1 | 0 | 0 | Yes | No |
| 19232175 | SYSTEMS, APPARATUS, AND METHODS FOR WARMING FLUID FOR INTRAVENOUS INFUSION | June 2025 | March 2026 | Allow | 9 | 1 | 1 | No | No |
| 19021396 | AUTO-INJECTOR | January 2025 | July 2025 | Allow | 6 | 1 | 0 | No | No |
| 19022461 | AUTO-INJECTOR | January 2025 | August 2025 | Allow | 7 | 1 | 0 | No | No |
| 19021912 | AUTO-INJECTOR | January 2025 | March 2025 | Allow | 2 | 0 | 0 | Yes | No |
| 19021557 | AUTO-INJECTOR | January 2025 | July 2025 | Allow | 6 | 0 | 0 | Yes | No |
| 19020238 | AUTO-INJECTOR | January 2025 | July 2025 | Allow | 6 | 2 | 0 | No | No |
| 18815035 | MILK BOWL AND WEARABLE BREAST PUMP | August 2024 | July 2025 | Allow | 11 | 2 | 0 | No | No |
| 18680212 | Auto-injector | May 2024 | May 2025 | Allow | 11 | 1 | 1 | No | No |
| 18680366 | Auto-injector | May 2024 | May 2025 | Allow | 12 | 1 | 1 | Yes | No |
| 18679813 | Auto-injector | May 2024 | April 2025 | Allow | 10 | 2 | 0 | Yes | No |
| 18679896 | Auto-injector | May 2024 | July 2025 | Allow | 13 | 3 | 1 | Yes | No |
| 18680073 | Auto-injector | May 2024 | May 2025 | Allow | 11 | 1 | 1 | No | No |
| 18678521 | Auto-injector | May 2024 | January 2025 | Allow | 8 | 1 | 0 | Yes | No |
| 18678364 | Auto-injector | May 2024 | January 2025 | Allow | 8 | 1 | 0 | Yes | No |
| 18679377 | Auto-injector | May 2024 | May 2025 | Allow | 12 | 2 | 1 | No | No |
| 18678282 | Auto-injector | May 2024 | September 2024 | Allow | 3 | 0 | 0 | Yes | No |
| 18598482 | HEMOSTASIS VALVES AND METHODS OF USE | March 2024 | July 2024 | Allow | 5 | 0 | 1 | Yes | No |
| 18504447 | Fluid Delivery Device | November 2023 | February 2026 | Allow | 27 | 1 | 1 | No | No |
| 18354139 | Syringe Warmer | July 2023 | July 2025 | Allow | 24 | 1 | 1 | Yes | No |
| 18220128 | MEDICAMENT DELIVERY DEVICE | July 2023 | September 2025 | Allow | 26 | 2 | 0 | No | No |
| 18206738 | SYSTEM AND METHOD FOR CLOSED-LOOP PATIENT-ADAPTIVE HEMODYNAMIC MANAGEMENT | June 2023 | February 2025 | Allow | 20 | 0 | 1 | No | No |
| 18328866 | Method and system for providing a therapeutic agent to an implanted infusion device | June 2023 | November 2025 | Allow | 30 | 2 | 1 | No | No |
| 18196927 | CONTACT SENSOR FOR MONITORING MEDICATION ADHERENCE | May 2023 | August 2025 | Abandon | 27 | 1 | 0 | No | No |
| 18142518 | HEMOSTASIS VALVES AND METHODS OF USE | May 2023 | August 2023 | Allow | 3 | 0 | 0 | No | No |
| 18310746 | Packaging Assembly | May 2023 | February 2026 | Allow | 34 | 2 | 1 | Yes | No |
| 18306528 | MEDICAMENT DELIVERY DEVICE | April 2023 | April 2025 | Allow | 23 | 1 | 0 | No | No |
| 18135636 | DEVICES AND METHODS FOR INSTALLATION AND REMOVAL OF A NEEDLE TIP OF A NEEDLE | April 2023 | April 2025 | Allow | 24 | 1 | 0 | No | No |
| 18246631 | DRUG DELIVERY DEVICE CASSETTE | March 2023 | November 2024 | Allow | 19 | 3 | 1 | Yes | No |
| 18102325 | Devices and Methods for Fluid Transfer Through a Placed Peripheral Intravenous Catheter | January 2023 | June 2023 | Allow | 4 | 0 | 1 | No | No |
| 18085193 | MEDICAMENT DELIVERY DEVICE | December 2022 | September 2024 | Allow | 21 | 0 | 0 | Yes | No |
| 17989314 | DYNAMICALLY CONTROLLABLE PATIENT FLUID CONTROL DEVICE | November 2022 | March 2025 | Allow | 28 | 1 | 0 | Yes | No |
| 17981154 | APPARATUS AND METHODS FOR INTRAVENOUS GAS ELIMINATION | November 2022 | July 2025 | Abandon | 33 | 1 | 1 | No | No |
| 17971266 | EXPANDABLE MOUTH CATHETER | October 2022 | February 2024 | Allow | 16 | 2 | 0 | Yes | No |
| 18047729 | Deformable Drug Reservoir For Wearable Drug Delivery Device | October 2022 | April 2025 | Allow | 29 | 1 | 1 | No | No |
| 17935237 | AUTO-INJECTOR | September 2022 | April 2025 | Allow | 30 | 1 | 0 | Yes | No |
| 17888327 | COMPUTERIZED ORAL PRESCRIPTION ADMINISTRATION WITH REFILLABLE MEDICATION DISPENSING DEVICES AND ASSOCIATED SYSTEMS AND METHODS | August 2022 | August 2024 | Allow | 24 | 0 | 0 | No | No |
| 17819780 | DEVICE AND METHOD FOR SINGLE-HANDED ACCESS AND INSERTION OF AN ARTICLE | August 2022 | July 2024 | Allow | 23 | 0 | 1 | No | No |
| 17886584 | ROBOTIC SURGICAL INSTRUMENTS | August 2022 | October 2025 | Allow | 39 | 0 | 1 | No | No |
| 17870988 | DISPLAY FOR WEARABLE DRUG DELIVERY DEVICE | July 2022 | June 2025 | Abandon | 34 | 2 | 1 | No | No |
| 17865266 | HEMOSTASIS VALVES AND METHODS OF USE | July 2022 | November 2022 | Allow | 4 | 0 | 1 | Yes | No |
| 17745007 | OCULAR IMPLANT DELIVERY DEVICE AND METHOD | May 2022 | February 2025 | Allow | 33 | 1 | 1 | Yes | No |
| 17734764 | SYSTEMS FOR WEARABLE INFUSION PORT AND ASSOCIATED PUMP | May 2022 | August 2024 | Allow | 28 | 0 | 0 | No | No |
| 17721613 | COMPONENT POSITIONING OF A LINEAR SHUTTLE PUMP | April 2022 | August 2024 | Allow | 28 | 0 | 0 | Yes | No |
| 17657119 | Device and Method for Single-Handed Access and Insertion of an Article | March 2022 | May 2024 | Allow | 26 | 0 | 1 | No | No |
| 17706380 | AUTO-INJECTOR | March 2022 | July 2025 | Allow | 39 | 1 | 1 | No | No |
| 17705189 | HEMOSTASIS VALVES AND METHODS OF USE | March 2022 | December 2022 | Allow | 9 | 1 | 1 | Yes | No |
| 17685149 | AMBULATORY MEDICAMENT DEVICE WITH MOTION DETECTION AND GESTURE-BASED CONTROL | March 2022 | August 2022 | Allow | 6 | 0 | 1 | No | No |
| 17588666 | VIAL CLOSURE FOR REHYDRATING MEDICATION | January 2022 | June 2025 | Allow | 40 | 2 | 0 | Yes | No |
| 17624631 | MEDICAL FLUID INJECTION AND TRANSFER DEVICES AND METHOD | January 2022 | August 2025 | Allow | 44 | 1 | 1 | Yes | No |
| 17555834 | THIN-WALLED TUBES WITH COMMUNICATION PATHWAYS | December 2021 | September 2025 | Abandon | 45 | 0 | 1 | No | No |
| 17554125 | COAXIAL BI-DIRECTIONAL CATHETER | December 2021 | June 2024 | Allow | 30 | 0 | 0 | Yes | No |
| 17552407 | LINEAR SHUTTLE PUMP FOR DRUG DELIVERY | December 2021 | November 2024 | Allow | 35 | 0 | 1 | No | No |
| 17552337 | Buffering Agent Cartridge | December 2021 | July 2024 | Allow | 31 | 0 | 1 | Yes | No |
| 17528319 | Imaging Marker | November 2021 | February 2026 | Abandon | 51 | 4 | 0 | No | No |
| 17522878 | RAPID DELIVERY AND/OR RECEIVING OF FLUIDS | November 2021 | May 2024 | Allow | 30 | 0 | 0 | Yes | No |
| 17604781 | Wearable Injector | October 2021 | April 2022 | Allow | 6 | 0 | 0 | Yes | No |
| 17504387 | BEND-LIMITED CATHETERS | October 2021 | October 2024 | Abandon | 36 | 0 | 1 | No | No |
| 17496432 | MEDICAL INSTRUMENT ELECTRICALLY ENERGIZED USING DRIVE CABLES | October 2021 | November 2024 | Allow | 38 | 1 | 1 | Yes | No |
| 17492007 | BLOOD GLUCOSE CONTROL SYSTEM WITH MEDICAMENT BOLUS RECOMMENDATION | October 2021 | December 2024 | Abandon | 38 | 1 | 1 | Yes | No |
| 17489610 | SYSTEM AND METHODS FOR WIRELESS DRUG DELIVERY ON COMMAND | September 2021 | July 2024 | Allow | 34 | 1 | 1 | Yes | No |
| 17489056 | Infusion Pump Assembly | September 2021 | August 2024 | Allow | 35 | 1 | 0 | Yes | No |
| 17486517 | AMBULATORY MEDICAL DEVICE WITH MALFUNCTION ALERT PRIORITIZATION | September 2021 | February 2024 | Allow | 28 | 0 | 1 | Yes | No |
| 17465775 | Conduit for Transseptal Passage to the Aorta | September 2021 | April 2024 | Allow | 31 | 0 | 0 | Yes | No |
| 17460594 | FIXATION OF RESERVOIR OF DRUG DELIVERY DEVICE | August 2021 | April 2024 | Allow | 32 | 0 | 0 | Yes | No |
| 17446297 | Annealing of Discrete Sections of a Reinforcement Layer to Modulate Stiffness of a Catheter | August 2021 | June 2025 | Abandon | 45 | 4 | 0 | Yes | No |
| 17412729 | WEARABLE MICRO-DOSING DRUG DELIVERY DEVICE | August 2021 | May 2024 | Allow | 33 | 1 | 1 | No | No |
| 17408554 | Infusion Pump Apparatus, Method and System | August 2021 | August 2024 | Allow | 36 | 1 | 0 | No | No |
| 17396265 | SERVICING REGIME FOR A DISPOSABLE SET OF A MEDICAL FLUID THERAPY MACHINE | August 2021 | November 2025 | Allow | 52 | 2 | 1 | Yes | No |
| 17444421 | METHOD AND APPARATUS FOR INJECTING FLUIDS | August 2021 | April 2024 | Allow | 32 | 0 | 0 | No | No |
| 17443565 | INTERLOCKING SYSTEM AND METHOD FOR JOYSTICKS IN A CATHETER PROCEDURE SYSTEM | July 2021 | May 2024 | Allow | 34 | 1 | 0 | Yes | No |
| 17424729 | Feeding Cap, Drive Head, And Drive System | July 2021 | July 2024 | Allow | 35 | 0 | 1 | Yes | No |
| 17380997 | DEVICES, SYSTEMS, AND METHODS USEFUL TO ENGAGE TISSUE USING SUCTION AND TO PERFORM MEDICAL PROCEDURES DURING SUCTIONAL ENGAGEMENT | July 2021 | June 2024 | Abandon | 35 | 0 | 1 | No | No |
| 17377491 | COAXIAL BI-DIRECTIONAL CATHETER | July 2021 | July 2024 | Allow | 36 | 1 | 0 | Yes | No |
| 17417820 | SHELL FOR A PORTABLE ELECTROMECHANICAL APPARATUS FOR DRUG INFUSION | June 2021 | November 2024 | Allow | 41 | 2 | 0 | No | No |
| 17349209 | CROSSING OCCLUSIONS IN BLOOD VESSELS | June 2021 | October 2025 | Allow | 52 | 6 | 0 | No | Yes |
| 17347994 | METHODS FOR IN SITU FABRICATION OF SENSOR ELECTRODES, AND MEDICAL SYSTEMS AND DEVICES EMPLOYING SUCH SENSOR ELECTRODES | June 2021 | September 2025 | Abandon | 51 | 0 | 1 | No | No |
| 17329795 | METHOD OF TREATMENT FOR VARIOUS DISEASES | May 2021 | May 2024 | Abandon | 36 | 0 | 1 | No | No |
| 17329823 | METHOD OF TREATMENT FOR VARIOUS DISEASES | May 2021 | May 2024 | Abandon | 36 | 0 | 1 | No | No |
| 17329765 | METHOD OF TREATMENT FOR VARIOUS DISEASES | May 2021 | May 2024 | Abandon | 36 | 0 | 1 | No | No |
| 17329842 | METHOD OF TREATMENT FOR VARIOUS DISEASES | May 2021 | June 2024 | Abandon | 37 | 0 | 1 | No | No |
| 17330132 | SYSTEMS AND METHODS FOR MASS AIR FLOW CONTROL IN VACUUM BASED ASPIRATION IN SURGICAL SYSTEM | May 2021 | March 2024 | Allow | 34 | 0 | 0 | No | No |
| 17246116 | Deformable Drug Reservoir For Wearable Drug Delivery Device | April 2021 | July 2022 | Allow | 14 | 2 | 1 | Yes | No |
| 17287261 | Stopcock | April 2021 | April 2025 | Abandon | 48 | 2 | 0 | No | No |
| 17284761 | Stepping Doser | April 2021 | November 2024 | Abandon | 44 | 1 | 0 | No | No |
| 17226318 | HEMOSTASIS VALVES AND METHODS OF USE | April 2021 | October 2023 | Allow | 30 | 0 | 0 | Yes | No |
| 17222570 | CLOSED-LOOP CONTROL IN STEADY-STATE CONDITIONS | April 2021 | October 2023 | Allow | 30 | 0 | 0 | No | No |
| 17218464 | APPLICATOR FOR DELIVERY OF A PRODUCT THERETHROUGH | March 2021 | January 2024 | Allow | 34 | 1 | 0 | No | No |
| 17281271 | SUBCUTANEOUS DELIVERY MECHANISM FOR DRUG DELIVERY DEVICE | March 2021 | August 2021 | Allow | 4 | 0 | 0 | Yes | No |
| 17216246 | SELF-CONTAINED SPRING INSERTER FOR DRUG DELIVERY INFUSION SET | March 2021 | August 2023 | Allow | 29 | 0 | 0 | Yes | No |
| 17057632 | AUTOMATED SYSTEM FOR MONITORING A PATIENT'S BLOOD SUGAR | March 2021 | February 2024 | Allow | 39 | 0 | 0 | No | No |
| 17197420 | INTEGRATED USER-DEFINED INPUT INTO A CLOSED-LOOP GLUCOSE CONTROL SYSTEM | March 2021 | January 2022 | Abandon | 11 | 1 | 0 | No | No |
| 17180429 | Display for Wearable Drug Delivery Device | February 2021 | April 2022 | Allow | 13 | 2 | 1 | Yes | No |
| 17180221 | Sensing Fluid Flow Irregularities In An On-Body Injector | February 2021 | May 2021 | Allow | 3 | 0 | 0 | Yes | No |
| 17179070 | AUTOMATED SUPER BOLUS GENERATION | February 2021 | August 2023 | Allow | 30 | 0 | 0 | No | No |
| 17160036 | NEEDLE-LESS INJECTOR AND METHOD OF FLUID DELIVERY | January 2021 | September 2023 | Allow | 32 | 0 | 1 | No | No |
| 17157211 | FLUTE CATHETER AND METHODS OF USING THE SAME | January 2021 | November 2024 | Abandon | 45 | 0 | 1 | No | No |
| 17153254 | DEVICES, SYSTEMS AND METHODS FOR MEDICAMENT DELIVERY | January 2021 | March 2024 | Abandon | 38 | 0 | 1 | No | No |
| 17256735 | Vascular Access Tube | December 2020 | February 2025 | Abandon | 49 | 2 | 1 | No | No |
| 17123369 | TECHNIQUES FOR IMPROVED AUTOMATIC DRUG DELIVERY PERFORMANCE USING DELIVERY TENDENCIES FROM PAST DELIVERY HISTORY AND USE PATTERNS | December 2020 | July 2023 | Allow | 31 | 0 | 1 | No | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner VU, QUYNH-NHU HOANG.
With a 14.3% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is below the USPTO average, indicating that appeals face more challenges here than typical.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 33.3% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is above the USPTO average, suggesting that filing an appeal can be an effective strategy for prompting reconsideration.
⚠ Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.
✓ Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.
Examiner VU, QUYNH-NHU HOANG works in Art Unit 3783 and has examined 456 patent applications in our dataset. With an allowance rate of 73.7%, this examiner has a below-average tendency to allow applications. Applications typically reach final disposition in approximately 35 months.
Examiner VU, QUYNH-NHU HOANG's allowance rate of 73.7% places them in the 38% percentile among all USPTO examiners. This examiner has a below-average tendency to allow applications.
On average, applications examined by VU, QUYNH-NHU HOANG receive 1.88 office actions before reaching final disposition. This places the examiner in the 45% percentile for office actions issued. This examiner issues fewer office actions than average, which may indicate efficient prosecution or a more lenient examination style.
The median time to disposition (half-life) for applications examined by VU, QUYNH-NHU HOANG is 35 months. This places the examiner in the 41% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.
Conducting an examiner interview provides a +31.9% benefit to allowance rate for applications examined by VU, QUYNH-NHU HOANG. This interview benefit is in the 80% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 26.0% of applications are subsequently allowed. This success rate is in the 42% percentile among all examiners. Strategic Insight: RCEs show below-average effectiveness with this examiner. Carefully evaluate whether an RCE or continuation is the better strategy.
This examiner enters after-final amendments leading to allowance in 18.7% of cases where such amendments are filed. This entry rate is in the 22% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.
When applicants request a pre-appeal conference (PAC) with this examiner, 126.3% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 84% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences are highly effective with this examiner compared to others. Before filing a full appeal brief, strongly consider requesting a PAC. The PAC provides an opportunity for the examiner and supervisory personnel to reconsider the rejection before the case proceeds to the PTAB.
This examiner withdraws rejections or reopens prosecution in 80.6% of appeals filed. This is in the 74% percentile among all examiners. Of these withdrawals, 62.1% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows above-average willingness to reconsider rejections during appeals. The mandatory appeal conference (MPEP § 1207.01) provides an opportunity for reconsideration.
When applicants file petitions regarding this examiner's actions, 51.9% are granted (fully or in part). This grant rate is in the 51% percentile among all examiners. Strategic Note: Petitions show above-average success regarding this examiner's actions. Petitionable matters include restriction requirements (MPEP § 1002.02(c)(2)) and various procedural issues.
Examiner's Amendments: This examiner makes examiner's amendments in 3.5% of allowed cases (in the 81% percentile). Per MPEP § 1302.04, examiner's amendments are used to place applications in condition for allowance when only minor changes are needed. This examiner frequently uses this tool compared to other examiners, indicating a cooperative approach to getting applications allowed. Strategic Insight: If you are close to allowance but minor claim amendments are needed, this examiner may be willing to make an examiner's amendment rather than requiring another round of prosecution.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 49% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.